Niki BiosolutionsNIKI
13F holders, Q2 2026 (June 30)5holders −3
2new positions
5sold out
1famous investor
$0.78avg. 13F price*
At the end of Q2 2026, 5 institutions reported holding Niki Biosolutions Inc. (NIKI) in their 13F filings, down 3 from Q1 2026. 2 opened new positions and 5 sold out. The largest holders were Jane Street Group, LLC ($46K), Citadel Advisors ($19K) and Citigroup Inc. ($5K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Niki Biosolutions Inc.
- Filed as
- APTORUM GROUP LIMITED (Q2 2026)
- CUSIP
- G6096M122
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $51K |
| Exits | 5 | $47K |
All 13F filers, Q1 2026 → Q2 2026: 64,859 shares bought and 126,495 shares sold, net −61,636 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Jane Street Group, LLC | 0.00% | New | 58,461 | $46K |
| Citadel Advisors | 0.00% | Reduce -73.5% | 24,492 | $19K |
| Citigroup Inc. | 0.00% | New | 6,398 | $5K |
| Osaic Holdings, Inc. | 0.00% | No change | 5,500 | $4K |
| SBI Securities Co., Ltd. | 0.00% | No change | 7 | $5 |
"% of holder's portfolio" is NIKI's weight in each manager's 13F, not the share of Niki Biosolutions Inc. the manager owns.